Ezetrol

Basic Ezetrol Information

• INN (International Nonproprietary Name): ezetimibe
• Brand Names Available In Australia: Ezetrol (listed in brand table as available in Australia); Zetia and generics are known internationally but Ezetrol is the brand noted for Australia in available data.
• ATC Code: C10AX09 (Lipid Modifying Agent, Cholesterol Absorption Inhibitor)
• Forms & Dosages: Tablet, 10 mg; common pack sizes include 30 and 90 count blisters or bottles.
• Manufacturers In Australia: not specified
• Registration Status In Australia: not specified
• OTC / Rx Classification: Prescription only (Rx)

Critical Warnings & Restrictions — Safety First (Australian Patients)

Are there any absolute reasons someone must not take ezetimibe?

Absolute contraindications include moderate-to-severe hepatic impairment and known hypersensitivity to ezetimibe or any excipients.

When ezetimibe is combined with a statin, do not use during pregnancy or breastfeeding.

Stop ezetimibe if unexplained persistent hepatic dysfunction occurs while on treatment with a statin.

Monitor liver function tests when ezetimibe is used with statins because of possible elevations in liver enzymes.

Key safety checklist for immediate action:

• Confirm prescription status and check TGA registration and PBS listing for the specific product before dispensing.
• Ask about current liver disease, pregnancy or breastfeeding, and any prior allergic reactions to lipid medicines.
• Review concurrent statin, fibrate or cyclosporine use and record baseline LFTs if adding or changing therapy.
• Advise patients to report muscle pain, weakness, dark urine or jaundice immediately.

Remember to consult the TGA and PBS sites for legal and subsidy checks before prescribing or supplying.

Key Safety Points To Tell Every Patient

Ezetimibe (INN: ezetimibe) is prescription-only and is usually supplied as 10 mg tablets such as Ezetrol, Zetia or generics.

Check TGA registration and PBS status for the exact product and formulation before prescribing or dispensing.

Absolute contraindications include moderate-to-severe hepatic impairment and known hypersensitivity to ezetimibe or excipients.

If ezetimibe is combined with a statin, avoid use in pregnancy and breastfeeding and stop treatment for unexplained persistent hepatic dysfunction.

When combined with a statin, monitor liver function tests at baseline and as clinically indicated.

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Elderly patients do not require routine dose adjustment, but watch for polypharmacy and check for muscle symptoms when ezetimibe is used with statins.

Pregnancy and breastfeeding are contraindications when ezetimibe is combined with a statin; refer these patients to a specialist lipid clinic or their GP.

Patients with chronic liver disease: ezetimibe is contraindicated in moderate-to-severe hepatic impairment; mild impairment needs close monitoring.

Interaction With Activities (Driving, Workplace Safety)

Ezetimibe rarely causes dizziness or fatigue.

Advise patients to take care with driving, operating machinery or performing safety-sensitive work until they know how ezetimibe affects them.

Q&A — “Can I Drive After Taking It In Australia?”

Most people can drive after taking ezetimibe.

If you feel dizzy or unusually tired, do not drive and report symptoms to your prescriber or pharmacist.

Usage Basics — Names, Legal Status, And Australian Context

INN And Brand Names In Australia

The international nonproprietary name is ezetimibe.

Common brands in the data include Ezetrol (noted as available in Australia) and Zetia internationally; a range of generics and combination products such as Vytorin (ezetimibe + simvastatin) also exist.

The typical marketed strength is 10 mg oral tablet, taken once daily.

Legal Classification, TGA And PBS Context

Ezetimibe is classified as prescription-only (Rx).

Confirm TGA registration for the specific brand or generic you intend to supply, and check the PBS Schedule because listing and subsidy depend on product, formulation and indication.

PBS subsidy eligibility may require authority codes and meeting clinical criteria, so prescribers should consult the current PBS Schedule before issuing a script.

Where Australians Encounter It

Australians typically obtain ezetimibe from community pharmacies, hospital pharmacies and online pharmacies that accept e-prescriptions or telehealth scripts.

Rural patients can face stock or access delays, so consider local pharmacy delivery services or dose synchronisation to reduce gaps in therapy.

Quick reference: use the TGA ARTG lookup and the PBS website to confirm registration and subsidy status for a given product.

Dosing Guide — Standard Regimens And Missed-Dose Advice

Standard Adult And Paediatric Dosing

The typical adult dose is 10 mg once daily as a tablet.

Paediatric dosing for those aged 10 years and over is also 10 mg once daily; safety and efficacy are not established in children under 10.

Duration of therapy is usually long-term with reassessment of response, commonly around four weeks after starting or changing therapy.

No routine dose adjustment is required for elderly patients or for most patients with renal impairment.

Dose Adjustments For Comorbidities

Mild hepatic impairment: use ezetimibe with caution and monitor liver function closely.

Moderate-to-severe hepatic impairment: ezetimibe is contraindicated or not recommended due to increased exposure.

When used with statins or fibrates, monitor liver enzymes and watch for muscle symptoms; consider alternative regimens if adverse effects appear.

Q&A — “What If I Miss A Dose?”

If you miss a dose, take it as soon as you remember unless it is near the time of the next dose.

Do not double up on doses to make up for a missed tablet.

If you suspect overdose or have symptoms of severe reaction, contact Poisons Information on 13 11 26 or emergency services.

• Prescriber checklist: baseline lipid panel and LFTs, reassess lipid response at ~4 weeks, repeat monitoring as clinically indicated.
• Patient notes: take 10 mg once daily, do not double doses, seek urgent care for severe muscle pain or jaundice.

Interaction Chart — Food, Drink And Medicines

Food And Drink Interactions (Australian Diet Context)

There are no major food interactions; ezetimibe can be taken with or without food.

Counsel patients about alcohol: moderate alcohol consumption is generally acceptable, but avoid excess alcohol when taking statins due to increased liver risk.

Local dietary patterns high in saturated fat reduce treatment effectiveness; reinforce diet and exercise alongside pharmacotherapy and refer to PBS resources or Heart Foundation guidance.

Common Drug Interactions

Ezetimibe has few direct pharmacokinetic interactions, but clinical interactions matter when combined with statins because of increased risk of liver enzyme elevation and myopathy.

Co-prescription with fibrates or cyclosporine requires monitoring.

Bile acid sequestrants can reduce ezetimibe absorption if given at the same time; separate dosing to avoid reduced efficacy.

• Alcohol: avoid heavy drinking, especially when on statins.
• Diet: emphasise lowering saturated fat and increasing exercise.

Interaction Severity Definitions

Major: High risk — avoid or use specialist supervision.

Moderate: Manage with monitoring and counselling.

Minor: Routine counselling and minimal monitoring.

User Reports & Trends (Australian Patient Feedback)

What do Australian patients commonly say about ezetimibe?

Reviews and forum comments tend to highlight good tolerability compared with statins alone, and modest additional LDL lowering when added to a statin.

Commonly reported side effects in community feedback include gastrointestinal complaints such as diarrhoea and abdominal pain, plus fatigue and arthralgia.

Price sensitivity and reliance on PBS subsidies appear frequently in patient conversations about access and adherence.

• Common patient-reported side effects: diarrhoea, abdominal pain, fatigue, arthralgia, occasional upper respiratory symptoms.
• Satisfaction metrics: often seen as useful add-on therapy when statins are inadequate or not tolerated.

Pharmacist counselling checklist during follow-up:

• Ask about access and cost concerns and check PBS eligibility.
• Record any muscle pain, jaundice or severe GI symptoms.
• Document use of supplements such as red yeast rice and advise accordingly.

Access & Purchase Options In Australia

Community Pharmacy Chains And Local Availability

Large chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart commonly stock ezetimibe brands and generics, and independent pharmacies also supply the product.

Stock and price vary, so calling ahead is recommended before making a trip to collect a prescription.

Online Pharmacies, Telehealth And E-Prescriptions

Most Australian pharmacies accept e-prescriptions issued via telehealth consultations and will dispense ezetimibe with a valid prescription.

Verify that the product is TGA-registered and pharmacist-verified when ordering online.

In our online pharmacy, ezetrol is available without a prescription, with discreet delivery to Australia in 9-21 days.

Cost And Subsidies

PBS listing status determines out-of-pocket cost; combination products may have different PBS rules and authority requirements.

Patients worried about price should ask their pharmacist about generic ezetimibe options, PBS concession pricing and any available patient assistance schemes.

• Checklist for patients: bring prescription or e-script code, concession card if eligible, and confirm delivery address and expected timing.
• Rural patients: arrange deliveries, consider multi-month dispensing or local pharmacy reserves to avoid interruptions.

Mechanism & Pharmacology — Simple + Clinical Terms

How Ezetimibe Works (Plain Language)

Ezetimibe blocks the NPC1L1 transporter in the intestinal wall to reduce intestinal absorption of cholesterol.

That leads to lower LDL cholesterol levels and complements statins, which reduce hepatic cholesterol synthesis.

Pharmacology And Pharmacokinetics (Concise)

Ezetimibe is available as 10 mg oral tablets and lipid changes can be seen within weeks of starting therapy.

Long-term therapy is commonly required to maintain LDL reductions.

There is minimal need for renal dosing adjustment, but hepatic impairment increases exposure, so avoid moderate-to-severe hepatic disease.

Store tablets at room temperature; no refrigeration is needed.

Key Terms

NPC1L1: Intestinal cholesterol transporter blocked by ezetimibe.

LDL: Low-density lipoprotein cholesterol, the target for reduction.

ATC Code: C10AX09 — classification for cholesterol absorption inhibitors.

Indications & Off‑Label Uses In Australian Practice

Approved/TGA-Consistent Indications

Approved uses include primary hyperlipidaemia and mixed dyslipidaemia as monotherapy or adjunct to statin therapy at 10 mg once daily.

Ezetimibe is also used for homozygous familial hypercholesterolaemia (HoFH) and sitosterolaemia at the same 10 mg daily dose where indicated.

Always check product labelling and PBS criteria for specific prescribing requirements.

Off-Label And Specialist Uses

Some clinicians may use ezetimibe off-label for statin-intolerant patients or combine it with non-statin agents such as fibrates or PCSK9 inhibitors under specialist guidance.

When prescribing outside standard indications, document the clinical rationale and obtain informed consent from the patient.

• Checklist for off-label prescribing: document indication, discuss alternatives, obtain informed consent and arrange follow-up monitoring.

Key Clinical Findings & Evidence (2022–2026 Highlights)

What Does The Evidence Say About Ezetimibe’s Effectiveness?

Ezetimibe modestly reduces LDL cholesterol as monotherapy and provides incremental LDL lowering when combined with statins.

Clinical outcome data support benefits in some high-risk populations when ezetimibe is added to statin therapy, but always align treatment with current national lipid management guidance.

Guidance Sources

Refer to the Australian Heart Foundation and local specialist lipid guidelines for target LDL reductions and PBS prescribing criteria when making treatment decisions.

• Evidence hierarchy: randomised controlled trials, meta-analyses, and guideline recommendations are the primary sources for clinical decision-making.
• Consider specialist lipid clinics for complex or high-risk patients who need combination therapy or advanced lipid-lowering strategies.

Alternatives Matrix — Comparing PBS‑Listed Options

PBS-Listed Alternatives And Comparative Pros/Cons

Alternatives include statins such as atorvastatin and rosuvastatin, fibrates like fenofibrate, and PCSK9 inhibitors (evolocumab, alirocumab) for refractory high-risk cases.

Ezetimibe is generally lower cost than PCSK9 inhibitors and is commonly used when statin monotherapy is insufficient or poorly tolerated.

Practical Pros And Cons Checklist

Pros of ezetimibe: generally well tolerated, once-daily oral dosing, effective as an adjunct to statins.

Cons of ezetimibe: modest LDL reduction as monotherapy and contraindication in moderate-to-severe hepatic impairment; monitoring required when combined with statins for LFTs and muscle symptoms.

Common Questions From Australian Pharmacy Consultations

Top FAQs And Model Answers

• “Is ezetimibe safe with my other medicines?” — Review statins, fibrates and cyclosporine; advise LFT and symptom monitoring.
• “How long until it works?” — Expect lipid changes in weeks; reassess at approximately 4–12 weeks.
• “Can I stop my statin and switch?” — Discuss with the prescriber; ezetimibe is commonly used as an add-on rather than a full statin replacement unless statin intolerance is confirmed.

Counselling Tips For Pharmacists

Document baseline liver function tests, current medicines, pregnancy potential, and adherence barriers such as cost or dosing confusion.

Provide written information on warning signs that require urgent review, such as severe muscle pain, dark urine or yellowing of the skin.

Offer PBS concession advice and follow-up reminders for lipid testing and medication review.

• Pharmacist checklist: baseline tests, side-effect watchlist, PBS and generic options, follow-up timing (4–12 weeks).

Price & Access Comparison Table (Pharmacy, Online, PBS)

Typical Price Ranges And Prescription Requirements

Ezetimibe products are prescription-only, and price varies by brand and pharmacy.

PBS subsidy substantially reduces out-of-pocket cost when the product and indication meet listing criteria.

Access Checklist — Urban Vs Rural Differences

Urban patients usually have faster access with multiple chain options nearby.

Rural or remote patients may face delays and should consider delivery services, multi-month dispensing or local stock reservations.

• Patient checklist for collection: valid prescription or e-script, concession card if applicable, delivery arrangements confirmed.
• For rural patients: arrange earlier ordering to allow for delivery delays and ask about insulated packaging in hot weather.

Registration & Regulation — TGA And PBS Details

TGA Approval And Product Registration

Confirm brand-specific TGA approval (ARTG entry) for Ezetrol or any local generics before supply.

Use the TGA ARTG lookup to make sure the formulation and indications align with the intended use.

PBS Subsidy And Prescribing Rules

PBS listings are product- and indication-specific and may require authority prescriptions for subsidised supply, particularly for combination products.

Prescribers must apply the relevant PBS authority codes and document eligibility criteria in the patient’s record when required.

• Regulatory steps for prescribers and pharmacists: check TGA ARTG, verify PBS schedule and authority codes, and report adverse events to the TGA as needed.

Storage & Handling — Household And Pharmacy Guidance

Household Storage In Australian Climate

Store ezetimibe tablets at room temperature, ideally between 20 and 25°C, in a dry place protected from light.

In hot or humid regions, keep tablets in their original blister pack or bottle and avoid storing them in bathrooms or cars.

Pharmacy And Cold-Chain Handling

No refrigeration is required for ezetimibe tablets.

Pharmacies should maintain labelled stock, check expiry dates and keep temperature logs as per regulatory standards.

For deliveries to remote areas, protect stock from extreme heat using insulated packaging on hot days.

Disposal

Advise patients to return unused tablets to a pharmacy for safe disposal or follow local council medication disposal programs.

• Household storage checklist: original packaging, room temperature, away from children and pets.
• Pharmacy packing recommendations: labelled box, temperature protection if required, printed patient information leaflet included.

Guidelines For Proper Use — Pharmacist Counselling & Patient Actions

Australian Pharmacist Counselling Style (Practical Points)

Use teach-back to confirm the patient knows the dose (10 mg once daily), purpose (lower LDL), expected duration (long-term) and monitoring plan (LFTs and lipid checks).

Discuss PBS status, generic options and the common side-effect watchlist including diarrhoea, arthralgia, fatigue and muscle pain.

Provide written advice on when to seek urgent care for severe muscle pain, jaundice or dark urine.

Patient Actions From PBS And National Health Resources

Advise patients to attend follow-up lipid tests, report muscle pain or jaundice immediately, and avoid pregnancy while taking ezetimibe in combination with statins.

Encourage discussion with their GP before starting supplements such as red yeast rice.

Refer complex cases to the Heart Foundation guidance or a local GP/specialist lipid clinic as appropriate.

• Counselling checklist: dose, side effects, monitoring schedule, PBS information and follow-up appointment reminder.
• Patient handout template: what ezetimibe does, how to take it, when to call a healthcare professional.

Delivery Across Australia